387 related articles for article (PubMed ID: 16286931)
1. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Tavazoie SF; Alvarez VA; Ridenour DA; Kwiatkowski DJ; Sabatini BL
Nat Neurosci; 2005 Dec; 8(12):1727-34. PubMed ID: 16286931
[TBL] [Abstract][Full Text] [Related]
2. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
3. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
[TBL] [Abstract][Full Text] [Related]
5. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.
Waltereit R; Welzl H; Dichgans J; Lipp HP; Schmidt WJ; Weller M
J Neurochem; 2006 Jan; 96(2):407-13. PubMed ID: 16300636
[TBL] [Abstract][Full Text] [Related]
6. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Astrinidis A; Henske EP
Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
[TBL] [Abstract][Full Text] [Related]
7. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.
Ess KC; Kamp CA; Tu BP; Gutmann DH
Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742
[TBL] [Abstract][Full Text] [Related]
8. Generation of a conditional disruption of the Tsc2 gene.
Hernandez O; Way S; McKenna J; Gambello MJ
Genesis; 2007 Feb; 45(2):101-6. PubMed ID: 17245776
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH
Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811
[TBL] [Abstract][Full Text] [Related]
10. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
Rosner M; Freilinger A; Lubec G; Hengstschläger M
Int J Oncol; 2005 Nov; 27(5):1411-24. PubMed ID: 16211238
[TBL] [Abstract][Full Text] [Related]
11. Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex.
Sugiura H; Yasuda S; Katsurabayashi S; Kawano H; Endo K; Takasaki K; Iwasaki K; Ichikawa M; Kobayashi T; Hino O; Yamagata K
Nat Commun; 2015 Apr; 6():6842. PubMed ID: 25880340
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
Lee L; Sudentas P; Donohue B; Asrican K; Worku A; Walker V; Sun Y; Schmidt K; Albert MS; El-Hashemite N; Lader AS; Onda H; Zhang H; Kwiatkowski DJ; Dabora SL
Genes Chromosomes Cancer; 2005 Mar; 42(3):213-27. PubMed ID: 15578690
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.
Choi JE; Chae JH; Hwang YS; Kim KJ
Brain Dev; 2006 Aug; 28(7):440-6. PubMed ID: 16554133
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma.
Wilson C; Idziaszczyk S; Parry L; Guy C; Griffiths DF; Lazda E; Bayne RA; Smith AJ; Sampson JR; Cheadle JP
Hum Mol Genet; 2005 Jul; 14(13):1839-50. PubMed ID: 15888477
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds.
Wentink M; Nellist M; Hoogeveen-Westerveld M; Zonnenberg B; van der Kolk D; van Essen T; Park SM; Woods G; Cohn-Hokke P; Brussel W; Smeets E; Brooks A; Halley D; van den Ouweland A; Maat-Kievit A
Clin Genet; 2012 May; 81(5):453-61. PubMed ID: 21332470
[TBL] [Abstract][Full Text] [Related]
16. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1.
Wang Y; Greenwood JS; Calcagnotto ME; Kirsch HE; Barbaro NM; Baraban SC
Ann Neurol; 2007 Feb; 61(2):139-52. PubMed ID: 17279540
[TBL] [Abstract][Full Text] [Related]
17. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes.
Jansen LA; Uhlmann EJ; Crino PB; Gutmann DH; Wong M
Epilepsia; 2005 Dec; 46(12):1871-80. PubMed ID: 16393152
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in neurobiology of Tuberous Sclerosis Complex.
Napolioni V; Moavero R; Curatolo P
Brain Dev; 2009 Feb; 31(2):104-13. PubMed ID: 19028034
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.
Nellist M; Burgers PC; van den Ouweland AM; Halley DJ; Luider TM
Biochem Biophys Res Commun; 2005 Aug; 333(3):818-26. PubMed ID: 15963462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]